Description
INDICATIONS
1.Weight management
wegovy is used for weight loss and weight maintenance in addition to diet and physical activity in adults, who have:
• a BMI of 30 kg/m² or greater (with obesity) or
• a BMI of 27 kg/m² and less than 30 kg/m² (overweight) and weight-related health problems.
BMI (Body Mass Index) is a measure of your weight in relation to your height.
wegovy is used together with diet and physical activity for weight management in adolescents ages 12 years and above, who have
• obesity
• body weight >60kg
As an adolescent patient, you should only continue using wegovy if you have lost at least 5% of your BMI after 12 weeks on the 2.4 mg dose or maximum tolerated dose. Consult your doctor before you continue.
2.Risk reduction of serious heart issues in adults
wegovy is used in addition to diet and physical activity to reduce the risk of serious heart issues (heartrelated death, heart attacks, strokes) in adults with a history of heart disease (like a heart attack, stroke or poor blood flow to the limbs) and either obesity or overweight (BMI ≥27 kg/m2 ).
DIRECTIONS FOR USE
Dosage:
Adults
The recommended dose is 2.4 mg once weekly. Your treatment will start at a low dose which will be gradually increased over 16 weeks of treatment as follows:
• When you first start using wegovy, the starting dose is 0.25 mg once weekly.
• Your doctor will instruct you to gradually increase your dose every 4 weeks until you reach the recommended dose of 2.4 mg once weekly.
• Once you reach the recommended dose of 2.4 mg, do not increase this dose further.
Titration schedule:
-
Week 1–4: 0.25 mg once weekly
-
Week 5–8: 0.5 mg once weekly
-
Week 9–12: 1 mg once weekly
-
Week 13–16: 1.7 mg once weekly
-
Week 17 onward: 2.4 mg once weekly (maintenance dose)
Adolescents
(above 12 years of age) For adolescents, the same dose escalation schedule as for adults should be applied (see above). The dose should be increased until 2.4 mg (maintenance dose) or maximum tolerated dose has been reached. Weekly doses higher than 2.4 mg are not recommended.
How to use:
wegovy is given as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle.
• The best places to give the injection are the upper arms, stomach or upper legs.
• Before you use the pen for the first time, ask your doctor or nurse how to use it.
SIDE EFFECTS
Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, dizziness, burping, indigestion, bloating, decreased appetite, flatulence, injection site reactions, dehydration, gallstones, pancreatitis (rare), increased heart rate
PREGNANCY AND LACTATION
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
ACTIVE INGREDIENTS
Semaglutide
